Nexa3D Acquires Addifab, Launches Digital Tooling For Injection Molding
VENTURA, CALIF.--(BUSINESS WIRE)--
Nexa3D, the ultrafast polymer 3D printing leader, announced today that it completed the acquisition of Addifab, the originator of Freeform Injection Molding, a proprietary and patented digital tooling process that couples the design freedom of 3D printing with the mechanical performance of injection molding using thousands of tried-and-true engineering materials.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230404005730/en/
xMOLD resin prints highly complex and fully soluble molds on Nexa3D printers. (Photo: Business Wire)
The acquisition follows a successful year of joint go-to-market collaboration between the two companies in both North America and EMEA. The joint sales and marketing efforts resulted in converting dozens of customers from traditional tooling to digital tooling due to significant time and cost savings associated with this innovative approach. This transformative end-to-end solution combines the best of Nexa3D’s ultrafast 3D printers with Addifab’s high-impact, high-temperature soluble resins to print complex tools that are compatible with any injection molding feedstock, thereby delivering complex tooling at a fraction of the cost and time of other 3D printers or conventional tooling processes.
Most notably, the combined solution was used by Wilson Sporting Goods to accelerate the development of youth baseball bats. Wilson’s R&D team was able to produce and test multiple designs simultaneously using final manufacturing materials, something they could not have accomplished before with any other 3D printed tool.
“We are very excited to welcome the entire Addifab team to the growing Nexa3D family of people, products and partners democratizing access to dissolvable tooling for same day complex molded parts using the entire range of industrially proven plastics,” said Avi Reichental, Co-founder, Chairman and CEO of Nexa3D.
The combination of these two highly complementary technologies unlocks the full potential of digital tooling for injection molding combining the freedom of creation with the reliability and ubiquity of injection molding, uniquely positioning Nexa3D for accelerated growth in the fast-growing additive manufacturing space. The acquisition also adds foundational intellectual property and capabilities to Nexa3D’s product line and accelerates its resin formulation and industrial production initiatives. “We believe that the market validated strategic fit between our businesses and products, combined with the expanded capabilities in product development, next-gen resin formulation, channel coverage, manufacturing and marketing, will result in significant revenue and accretive growth,” said Reichental.
Located in Copenhagen, Denmark, Addifab developed, patented, and successfully brought to market a proprietary end-to-end digital tooling solution that includes CAD-to-Tool software generator, dissolvable tooling resins, 3D printing and production injection molding process. By combining the freedom of 3D printing with the industrial strength of injection molding, Addifab unlocks tremendous potential for contract manufacturers, regional molders, medical-device companies, service providers and low-volume manufacturers looking to take full advantage of the design freedom inherent to 3D printing while using tried-and-true injection molding plastic materials for same day and next day part production. This is because the xMOLD resin is compatible with the entire range of off-the-shelf thermoplastic materials, including reinforced high-performance feedstocks. Additionally, metals, ceramics, and silicones are also covered, enabling users of Nexa3D printers to tap into applications that would normally require a substantially larger capital investment. A tool printed with the xMOLD resin is soluble, meaning it does not require complex slides and gates, giving customers the ultimate flexibility to test and iterate more frequently. Finally, you don’t have to be a toolmaker to quickly design an injection molding tool using the Addifab tool maker software or Solidworks.
“Soon after teaming up with Nexa3D, it became increasingly apparent that our combined solution unlocks tremendous opportunities for customers looking to create complex injection molding tools quickly and affordably. A year into our enormously successful commercial collaboration and dozens of customer implementations with the likes of PepsiCo and Wilson Sporting Goods, I’m thrilled that we are officially joining forces,” said Lasse G. Staal, Co-founder and Business Development Leader at Addifab.
As part of its growing commitment to EMEA, and in service of its growing reseller partner network, Nexa3D plans to immediately leverage Addifab’s Copenhagen facility as its Customer Experience Center, inclusive of a product showroom, service and support hub for its European-based customers, and a main warehouse and logistics center in Europe. This move further emphasizes Nexa3D’s commitment to geographic expansion, customer success, and broadened access to its ultrafast 3D printing technology and digital tooling solutions.
Additional information is available on the Nexa3D website and in the media kit.
Nexa3D is passionate about digitizing supply chains sustainably as well as providing ultrafast 3D printing solutions for dental applications. The company makes ultrafast polymer 3D printers that deliver up to 20x productivity gains to professionals and businesses of all sizes. Partnerships with world-class material suppliers and its open materials platform unlock the full potential of additively manufactured polymers for volume production. Automated software tools optimize the entire production cycle using process interplay algorithms that ensure part performance and production consistency, while reducing waste, energy, and minimizing carbon footprint.
For more information on Nexa3D and its products, visit the Nexa3D website, or connect socially on LinkedIn, Twitter, Facebook, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230404005730/en/
Copyright Business Wire 2023